The year 2019 noted a remarkable year for biosimilar in the United States as in the year 2020 the FDA approved its 30th bio similar product and with its launch marked its 30th product in the list. As of now we are looking forward. Later in 2021 we this progress […]
Author: Deannaanderson
Pandemic and its after-effects in businesses
The rapidly evolving threat around the COVID-19 virus, commonly referred to as coronavirus, is impacting businesses around the globe. It is seen that companies, businesses, and governments are taking a measured approach to safeguard employees and mitigate financial and operational exposure. Needless to say, whether we like to admit it […]